Approval · Notice of Compliance 10077 · 2009
NOROCARP CAPLETS: Notice of Compliance 10077
Issued March 9, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10077
- Date
- March 9, 2009
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Non-steroidal anti-inflammatory
- Canadian reference product
- RIMADYL CAPLETS (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOROCARP CAPLETS | 02320649 | Cancelled Post Market |
Medicinal ingredients
- CARPROFEN 25 MG per TAB